A retrospective analysis of the clinicopathological features and prognostic value of MAPK12 protein expression in diffuse large B-cell lymphoma.

Yue LiuHan ZhangShu ZhaoYue Zhang

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)

DLBCL patients have poor prognoses when MAPK12 levels are high, which is expected to be a therapeutic target and prognostic factor.

Keyphrases

diffuse large b cell lymphoma
prognostic factors
epstein barr virus
signaling pathway
end stage renal disease
oxidative stress
ejection fraction
newly diagnosed
pi k akt
peritoneal dialysis